Relationship of adherence to pediatric asthma morbidity among inner-city children

Laurie J Bauman1, Elizabeth Wright, Frederick E Leickly

  • 1Department of Pediatrics, Albert Einstein College of Medicine and the Children's Hospital at Montefiore, Bronx, New York, USA. bauman@aecom.yu.edu

Pediatrics
|July 3, 2002
PubMed

Insights

Caregiver nonadherence to asthma medication significantly increases childhood asthma morbidity. Addressing nonadherence risks can improve health outcomes for inner-city children with asthma.

Area of Science:

  • Pediatric Health
  • Respiratory Medicine
  • Public Health

Background:

  • Childhood asthma is a major US health concern.
  • Nonadherence to asthma treatment is a significant factor in pediatric asthma morbidity.
  • Inner-city children face unique challenges in managing asthma.

Purpose of the Study:

  • To examine the relationship between baseline nonadherence and subsequent asthma morbidity in inner-city children.
  • To identify specific measures of nonadherence that predict asthma-related health outcomes.
  • To inform potential intervention strategies for improving asthma management in pediatric populations.

Main Methods:

  • A multisite, prospective, longitudinal panel study.
  • Involved 1199 children (aged 4-9 years) with asthma and their caregivers.
  • Assessed nine morbidity indicators at 3, 6, and 9 months, including hospitalizations, unscheduled visits, and symptom-related days.

Main Results:

  • High scores on Admitted Nonadherence and Risk for Nonadherence measures were significantly associated with worse asthma morbidity.
  • Nonadherence measures independently predicted increased hospitalizations, unscheduled visits, symptom days, and reduced activity.
  • Combined adherence measures provided improved estimates of morbidity, with dual nonadherence leading to doubled hospitalization rates and missed school days.

Conclusions:

  • Risk for Nonadherence and Admitted Nonadherence are independent and joint predictors of childhood asthma morbidity.
  • Targeting nonadherence risks presents a viable intervention strategy for reducing pediatric asthma burden.
  • Physician interventions, including simplifying regimens and improving communication, can mitigate nonadherence and its consequences.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...